Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal

dc.contributor.authorDewidar, Omar
dc.contributor.authorLotfi, Tamara
dc.contributor.authorLangendam, Miranda W.
dc.contributor.authorParmelli, Elena
dc.contributor.authorSaz-Parkinson, Z.
dc.contributor.authorSolo, Karla
dc.contributor.authorChu, Derek K.
dc.contributor.authorMathew, Joseph Lazar
dc.contributor.authorAkl, Elie A.
dc.contributor.authorBrignardello-Petersen, Romina
dc.contributor.authorMustafa, Reem A.
dc.contributor.authorMoja, Lorenzo P.
dc.contributor.authorIorio, A. M.
dc.contributor.authorChi, Yuan
dc.contributor.authorCanelo-Aybar, Carlos Gilberto
dc.contributor.authorKredo, Tamara J.
dc.contributor.authorKarpusheff, Justine
dc.contributor.authorTurgeon, Alexis F.
dc.contributor.authorAlonso-Coello, Pablo
dc.contributor.authorWiercioch, Wojtek
dc.contributor.authorGerritsen, Annette A.M.
dc.contributor.authorKlugar, Miloslav
dc.contributor.authorRojas, Maria X.
dc.contributor.authorTugwell, Peter S.L.
dc.contributor.authorWelch, Vivian A.
dc.contributor.authorPottie, Kevin C.
dc.contributor.authorMunn, Zachary
dc.contributor.authorNieuwlaat, Robby
dc.contributor.authorFord, Nathan P.
dc.contributor.authorStevens, Adrienne L.
dc.contributor.authorKhabsa, Joanne
dc.contributor.authorNasir, Zil H.
dc.contributor.authorLeontiadis, Grigorios I.
dc.contributor.authorMeerpohl, Joerg J.
dc.contributor.authorPiggott, Thomas
dc.contributor.authorQaseem, Amir
dc.contributor.authorMatthews, Micayla
dc.contributor.authorSchunëmann, Holger J.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentClinical Research Institute
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:53Z
dc.date.available2025-01-24T11:43:53Z
dc.date.issued2022
dc.description.abstractObjectives To evaluate the development and quality of actionable statements that qualify as good practice statements (GPS) reported in COVID-19 guidelines. Design and setting Systematic review. We searched MEDLINE, MedSci, China National Knowledge Infrastructure (CNKI), databases of Grading of Recommendations Assessment, Development and Evaluation (GRADE) Guidelines, NICE, WHO and Guidelines International Network (GIN) from March 2020 to September 2021. We included original or adapted recommendations addressing any COVID-19 topic. Main outcome measures We used GRADE Working Group criteria for assessing the appropriateness of issuing a GPS: (1) clear and actionable; (2) rationale necessitating the message for healthcare practice; (3) practicality of systematically searching for evidence; (4) likely net positive consequences from implementing the GPS and (5) clear link to the indirect evidence. We assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation II tool. Results 253 guidelines from 44 professional societies issued 3726 actionable statements. We classified 2375 (64%) as GPS; of which 27 (1%) were labelled as GPS by guideline developers. 5 (19%) were labelled as GPS by their authors but did not meet GPS criteria. Of the 2375 GPS, 85% were clear and actionable; 59% provided a rationale necessitating the message for healthcare practice, 24% reported the net positive consequences from implementing the GPS. Systematic collection of evidence was deemed impractical for 13% of the GPS, and 39% explained the chain of indirect evidence supporting GPS development. 173/2375 (7.3%) statements explicitly satisfied all five criteria. The guidelines' overall quality was poor regardless of the appropriateness of GPS development and labelling. Conclusions Statements that qualify as GPS are common in COVID-19 guidelines but are characterised by unclear designation and development processes, and methodological weaknesses. © 2022 BMJ Publishing Group. All rights reserved.
dc.identifier.doihttps://doi.org/10.1136/bmjebm-2021-111866
dc.identifier.eid2-s2.0-85128882586
dc.identifier.pmid35428695
dc.identifier.urihttp://hdl.handle.net/10938/30367
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.ispartofBMJ Evidence-Based Medicine
dc.sourceScopus
dc.subjectCovid-19
dc.subjectEvidence-based practice
dc.subjectHealth services research
dc.subjectChina
dc.subjectHumans
dc.subjectArticle
dc.subjectCoronavirus disease 2019
dc.subjectData base
dc.subjectHealth care practice
dc.subjectHuman
dc.subjectPractice guideline
dc.subjectSystematic review
dc.titleWhich actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1848.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format